Towards Antiviral Potential of Biomolecules Derived from Adhatod avasica as Competent Natural Molecules to Treat COVID-19 Virus Variant

• DOI: 10.2174/0115701786263427231123103651
• Publication Date: 2024-01-25T15:25:56Z
• Authors: Mohammad Asif; Mohd Yusuf; Mazen Almehmadi; Ahad Amer Alsaiari; Mamdouh Allahyani; Abdulelah Aljuaid; Abdulaziz Alsharif
• Keywords: Biomolecule; 2019-20 coronavirus outbreak

Abstract: Adhatoda vasica (L.) (Acanthaceae) has essential therapeutic roles and is widely used in the indigenous medicine system or Ayurvedic of medicine. The important goals present study are to report in-silico anti-corona (COVID-19) activity different phytochemicals A. vasica. This will help find specific bioactive compounds, their use as anti- COVID-19 action for human welfare. chemical phytoconstituents with diverse pharmacological activities. These have been found active against many diseases such antibacterial, antitubercular, antivirus, antitussive, hepatoprotective, antiinflammatory, antiulcer, antiurolithiatic, abortifacient, radio modulator, cardio-protection, antidiabetic, antioxidant, anticancer, thrombolytic, antimutagenic, etc. Researchers lured natural sustainable products substantial potential current climate environmental preservation safe use. materials permit biological activity, safety, compatibility environment. Using SARS-CoV-2 spike receptor (6M0J), we evaluated biomolecules Covid-19 variant (RBD- COV-2-S). very encouraging indicates that herbs should be studied more extensively benefits.